[go: up one dir, main page]

WO2000030653A3 - Utilisation de derives de phosphonoformate pour traiter des infections - Google Patents

Utilisation de derives de phosphonoformate pour traiter des infections Download PDF

Info

Publication number
WO2000030653A3
WO2000030653A3 PCT/EP1999/008964 EP9908964W WO0030653A3 WO 2000030653 A3 WO2000030653 A3 WO 2000030653A3 EP 9908964 W EP9908964 W EP 9908964W WO 0030653 A3 WO0030653 A3 WO 0030653A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid derivatives
treating infections
phosphonoformic acid
processes
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1999/008964
Other languages
German (de)
English (en)
Other versions
WO2000030653A2 (fr
Inventor
Hassan Jomaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EA200100585A priority Critical patent/EA200100585A1/ru
Priority to PL99348354A priority patent/PL348354A1/xx
Priority to BR9915605-9A priority patent/BR9915605A/pt
Priority to AU18591/00A priority patent/AU1859100A/en
Priority to EP99962147A priority patent/EP1133302A2/fr
Priority to CA002352511A priority patent/CA2352511A1/fr
Priority to JP2000583536A priority patent/JP2002530343A/ja
Priority to IL14277599A priority patent/IL142775A0/xx
Application filed by Individual filed Critical Individual
Priority to APAP/P/2001/002164A priority patent/AP2001002164A0/en
Publication of WO2000030653A2 publication Critical patent/WO2000030653A2/fr
Publication of WO2000030653A3 publication Critical patent/WO2000030653A3/fr
Priority to NO20012540A priority patent/NO20012540L/no
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention concerne un composé de la formule (I) pour assurer la prophylaxie et le traitement de processus infectieux chez l'homme et chez l'animal, induits par des bactéries, des moisissures ou des parasites. Ce composé s'utilise également comme fongicide, bactéricide ou herbicide dans le domaine végétal.
PCT/EP1999/008964 1998-11-25 1999-11-20 Utilisation de derives de phosphonoformate pour traiter des infections Ceased WO2000030653A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2000583536A JP2002530343A (ja) 1998-11-25 1999-11-20 感染症の治療のためのホスホノ蟻酸誘導体の使用
BR9915605-9A BR9915605A (pt) 1998-11-25 1999-11-20 Uso de derivados do ácido fosfonofórmico para o tratamento de infecções
AU18591/00A AU1859100A (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
EP99962147A EP1133302A2 (fr) 1998-11-25 1999-11-20 Utilisation de derives de phosphonoformate pour traiter des infections
CA002352511A CA2352511A1 (fr) 1998-11-25 1999-11-20 Utilisation de derives de phosphonoformate pour traiter des infections
EA200100585A EA200100585A1 (ru) 1998-11-25 1999-11-20 Применение производных фосфономуравьиной кислоты для лечения инфекций
PL99348354A PL348354A1 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
IL14277599A IL142775A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
APAP/P/2001/002164A AP2001002164A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections.
NO20012540A NO20012540L (no) 1998-11-25 2001-05-23 Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854310A DE19854310A1 (de) 1998-11-25 1998-11-25 Verwendung von Phosphonoameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
DE19854310.7 1998-11-25

Publications (2)

Publication Number Publication Date
WO2000030653A2 WO2000030653A2 (fr) 2000-06-02
WO2000030653A3 true WO2000030653A3 (fr) 2000-11-16

Family

ID=7888924

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/008964 Ceased WO2000030653A2 (fr) 1998-11-25 1999-11-20 Utilisation de derives de phosphonoformate pour traiter des infections

Country Status (16)

Country Link
EP (1) EP1133302A2 (fr)
JP (1) JP2002530343A (fr)
CN (1) CN1328464A (fr)
AP (1) AP2001002164A0 (fr)
AU (1) AU1859100A (fr)
BR (1) BR9915605A (fr)
CA (1) CA2352511A1 (fr)
CZ (1) CZ20011819A3 (fr)
DE (1) DE19854310A1 (fr)
EA (1) EA200100585A1 (fr)
IL (1) IL142775A0 (fr)
NO (1) NO20012540L (fr)
OA (1) OA11718A (fr)
PL (1) PL348354A1 (fr)
TR (1) TR200101431T2 (fr)
WO (1) WO2000030653A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1533279A (zh) * 2001-07-20 2004-09-29 �����ɷ� 用于活化γ/δT-细胞的有机磷化合物
EP1603542A1 (fr) * 2003-03-14 2005-12-14 Epistem Limited Traitement et/ou prevention d'une deterioration epitheliale non virale
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
CN104940211B (zh) * 2015-06-08 2018-06-19 广州万粤知识产权运营有限公司 白桦脂酸在制备抗真菌生物被膜药物中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012604A1 (fr) * 1993-11-05 1995-05-11 Aktiebolaget Astra Nouveaux derives d'acides amines
WO1998025938A1 (fr) * 1996-12-13 1998-06-18 Astra Aktiebolag (Publ) Nouveaux composes
RU2116790C1 (ru) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Наружное противоинфекционное средство "рефарм"
DE19859668A1 (de) * 1998-06-24 1999-12-30 Hassan Jomaa Verwendung von Bisphosphonaten zur Prophylaxe und zur Behandlung von infektiösen Prozessen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012604A1 (fr) * 1993-11-05 1995-05-11 Aktiebolaget Astra Nouveaux derives d'acides amines
WO1998025938A1 (fr) * 1996-12-13 1998-06-18 Astra Aktiebolag (Publ) Nouveaux composes
RU2116790C1 (ru) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Наружное противоинфекционное средство "рефарм"
DE19859668A1 (de) * 1998-06-24 1999-12-30 Hassan Jomaa Verwendung von Bisphosphonaten zur Prophylaxe und zur Behandlung von infektiösen Prozessen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; AN 2000-051535, XP002130244 *
KRÄMER, IRENE: "Viability of microorganisms in novel antineoplastic and antiviral drug solutions", J. ONCOL. PRACTICE, vol. 4, no. 1, 1998, pages 32 - 37, XP000872588 *

Also Published As

Publication number Publication date
IL142775A0 (en) 2002-03-10
AU1859100A (en) 2000-06-13
EP1133302A2 (fr) 2001-09-19
CZ20011819A3 (cs) 2001-12-12
PL348354A1 (en) 2002-05-20
EA200100585A1 (ru) 2002-04-25
JP2002530343A (ja) 2002-09-17
AP2001002164A0 (en) 2001-06-30
TR200101431T2 (tr) 2001-10-22
OA11718A (en) 2005-01-26
DE19854310A1 (de) 2000-06-29
CA2352511A1 (fr) 2000-06-02
BR9915605A (pt) 2001-08-14
NO20012540D0 (no) 2001-05-23
CN1328464A (zh) 2001-12-26
NO20012540L (no) 2001-07-24
WO2000030653A2 (fr) 2000-06-02

Similar Documents

Publication Publication Date Title
WO1999052515A3 (fr) Utilisation de liaisons organophosphorees dans le traitement et la prevention d'infections
WO2001028339A3 (fr) Composition antimicrobienne comprenant un acide organique biologiquement actif
AR087990A2 (es) Combinaciones de compuestos activos, metodo para controlar composiciones fungicidas e insecticidas, uso de esas combinaciones o composiciones para controlar hongos e insectos, y procedimiento para la preparacion de esas composiciones
DK0514768T3 (fr)
AU1401692A (en) Biguanide derivatives, manufacturing method thereof and disinfectants containing the derivatives
YU2201A (sh) Fosfororganska jedinjenja i njihova upotreba
MXPA04000874A (es) Composicion funguicida y uso de la composicion para controlar las enfermedades de las plantas.
WO2000030625A3 (fr) Utilisation de derives de phosphonoformate pour traiter des infections
WO2000044359A3 (fr) Utilisation de derives thiadiazoliques pour le traitement prophylactique et therapeutique d'infections
GT200200146A (es) Nuevos compuestos fungicidas
MY131067A (en) Selective herbicides comprising a tetrazolinone derivative
MXPA04004557A (es) Composicion fungicida basada en derivado de piridilmetilbenzamida y derivado de valinamida.
WO2000066094A3 (fr) Utilisation de composes comportant un heterocycle azote-oxygene
AP2001002106A0 (en) Use of organophosphorus compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide.
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
WO2000030653A3 (fr) Utilisation de derives de phosphonoformate pour traiter des infections
WO2000044358A3 (fr) Utilisation de composes organophosphores pour la prophylaxie et le traitement des infections
WO2003017766A3 (fr) Herbicides a base de cetones d'aryle substituees
WO1999063827A8 (fr) Agents permettant de lutter contre les dommages causes par des maladies bacteriennes dans les domaines de l'agriculture et de l'horticulture
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
ATE146458T1 (de) Insektizid- und akarizid-diphenyl-carbonitrile sowie diarylnitropyrrolderivate
WO2001092341A8 (fr) Compose de glucal, son procede de preparation et ses applications
WO2001049668A3 (fr) 4-aryl-1-difluoromethoxyimidazole
BRPI0415077A (pt) misturas fungicidas para combater patógenos de arroz, agente fungicida, processo para combater fungos nocivos, semente, e, uso de compostos

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99813747.2

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 142775

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2001/00511/MU

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 18591/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PV2001-1819

Country of ref document: CZ

Ref document number: 2001/01431

Country of ref document: TR

ENP Entry into the national phase

Ref document number: 2352511

Country of ref document: CA

Ref document number: 2352511

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 583536

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09856805

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1999962147

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200100585

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1999962147

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV2001-1819

Country of ref document: CZ

WWR Wipo information: refused in national office

Ref document number: PV2001-1819

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1999962147

Country of ref document: EP